about
Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesisGastric cancer development after the successful eradication of Helicobacter pyloriThe Fine LINE: Methylation Drawing the Cancer LandscapeDNA methylation and microRNAs in cancerEtiologic field effect: reappraisal of the field effect concept in cancer predisposition and progressionMultifocal epithelial tumors and field cancerization: stroma as a primary determinantRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaEpigenetic impact of infection on carcinogenesis: mechanisms and applicationsDifferences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancerUdp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancerEpigenetics: connecting environment and genotype to phenotype and diseasePatterns of DNA methylation in the normal colon vary by anatomical location, gender, and ageQuantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patientsDNA demethylation in normal colon tissue predicts predisposition to multiple cancers.Colorectal advanced neoplasms occur through dual carcinogenesis pathways in individuals with coexisting serrated polyps.Clinical implications of pre-existing adenoma in endoscopically resected early gastric cancersCancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architectureField cancerization in the intestinal epithelium of patients with Crohn's ileocolitis.Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction.Clinical potential of DNA methylation in gastric cancer: a meta-analysis.Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effectInhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing.Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort studyKlotho is silenced through promoter hypermethylation in gastric cancer.TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.Potential roles of DNA methylation in the initiation and establishment of replicative senescence revealed by array-based methylome and transcriptome analyses.LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer.Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerizationArray-based identification of common DNA methylation alterations in ulcerative colitisRisk Factors for Metachronous Gastric Neoplasms in Patients Who Underwent Endoscopic Resection of a Gastric Neoplasm.Infection, stem cells and cancer signals.Epigenetic field for cancerization: its cause and clinical implications.Fibulin 1 is downregulated through promoter hypermethylation in gastric cancerTumor size is an independent risk predictor for metachronous colorectal cancer.Hereditary diffuse gastric cancer and lost cell polarity: a short path to cancer.Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.Colonic crypt organization and tumorigenesis.
P2860
Q24631440-72453CA7-D5E6-4267-92A2-CB4FCCA06A55Q26753852-6195F6AF-8902-41BF-A37A-BAA4317243F4Q26785958-F3849ADB-E7FE-4925-9036-826875C7F6F2Q26852479-D1A4FC02-5E26-48ED-92B3-7C1DD45FDFFCQ26852716-A0115C71-4A66-4F04-AD41-418EF2C4673CQ27005678-94218893-99EC-4CBE-AD7E-049DA9C71334Q27023524-E8028D8E-B211-4E5B-9F30-40473F0D1A9BQ28066519-613117DD-4AE1-4D71-A6DF-B3830B1F4ECDQ28239338-25CAC071-CDE0-44D4-BF0B-3CAF59028503Q28392741-7DD50829-4E9B-4B7C-921D-E69EB0B35DC7Q28730790-915D3FBE-A876-4095-90D6-6EE6E4A37A19Q30585819-0A392E12-0C79-4EEE-B3FB-3DBEA599CDD6Q33540332-B33ED200-8978-42B8-AD26-3A44FA84F9A9Q33581249-64685AC6-E2A1-46AC-8959-2563E17126E3Q33645406-721D0535-A579-4C74-A9A2-A8E7C22C44C9Q33728597-41684BBB-2A82-47AF-B2CF-A8799500E917Q33920767-CC054438-AEED-4E69-944E-9B621DE6A2F7Q34032751-3144D330-D7F8-4997-BD32-028E38832482Q34104498-730AE822-03DF-4BC5-8465-63B336BAA600Q34193813-D77B539A-95F3-4B5C-880F-C6139DCFA244Q34257393-F0746185-572A-4980-9A6A-E7E7208D486FQ34353359-CB640B2A-9807-4F93-8206-816FCCB95CE4Q34535147-56D3F302-81EA-42C8-AFB9-602394F9D182Q34629266-3D830CCE-04C9-4EE0-87B5-7E1B1EE38144Q34976449-2CA5F9FE-9CEB-4A2B-90D4-05D3651AA34BQ35135769-7FE2531B-51B3-4AC0-ADA9-BFEDF758C68EQ35232389-5434A216-5C2C-40C1-986A-95C3356F046CQ35368917-A4C7E857-8FB4-4325-9FCE-432CD8DBE037Q36269849-1E53CB60-A3A3-4465-9235-D8FD3B98DD92Q36414307-F1D53D1F-79D4-4200-99C5-97083C7EBDD9Q36570696-42DEE4B8-6731-4B0C-8F04-A0055A0DF19EQ36645656-2ABA0B3F-9C5E-4F42-89BB-AF7239EE08B6Q36658411-DF83EFBB-5ED6-4CD0-A744-8C937A317D16Q36727010-28DD4A05-E499-4D58-9DC6-B8FA198F7EFFQ36760486-7105084B-392C-44B5-B760-C0D2770149C6Q37023915-9D67CD53-AF03-4B67-8F16-E5B68F1F3F4FQ37109630-304C68FE-DE2B-4002-B76D-FF0ADD7593CAQ37137010-3A4C5F64-8A33-4166-A484-AE71E14C9373Q37157383-BF3FDCCD-73FC-4306-8439-EC74802D4117Q37164065-9A130F4F-D615-40E5-9852-D1DD24FB4D56
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epigenetic field for cancerization.
@ast
Epigenetic field for cancerization.
@en
type
label
Epigenetic field for cancerization.
@ast
Epigenetic field for cancerization.
@en
prefLabel
Epigenetic field for cancerization.
@ast
Epigenetic field for cancerization.
@en
P1433
P1476
Epigenetic field for cancerization.
@en
P2093
Toshikazu Ushijima
P304
P356
10.5483/BMBREP.2007.40.2.142
P577
2007-03-01T00:00:00Z